{
  "id": "everyday#risk_safety_d5374c13",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "68 EPI 3 EPILEPSY Follow-up 2 MONITOR TREATMENT At every contact: » » Evaluate side-effects of medication including adverse effects Does the patient have any new symptoms of concern? and idiosyncratic reactions (clinically and with appropriate laboratory tests Review for any new symptoms of depression and anxiety given when available). high risk of co-morbidity with epilepsy. » » Provide psychoeducation and review psychosocial interventions. Is the patient on any new medications that may have interactions? » (Many anticonvulsants have interactions with other medications). If so, Is the person a woman of childbearing age and considering consult a specialist. pregnancy? If so, consult specialist. 3 CONSIDER MEDICATION DISCONTINUATION WHEN APPROPRIATE Has the person been convulsion free for several years? » D iscuss risk of seizure occurrence with person/carer IF THERE ARE NO PROBLEMS WITH MEDICATIONS (if epilepsy is due to head injury, stroke or neuroinfection, » Continue at current dose. Correct dosing is lowest there is a higher risk of seizure recurrence off medication), therapeutic dose for seizure control, while minimizing and risks and benefits of discontinuing medications. adverse side-effects. » If in agreement, gradually take the person off » Continue close follow-up and review for possible dis- medication by reducing the doses over 2 months and continuation of medications once seizure free for at monitoring closely for seizure recurrence. least two years. CHILD & ADOLESCENT",
  "gloss_vi": "68 epi 3 epilepsy follow-up 2 monitor treatment at every contact: » » evaluate side-effects of medication including adverse effects does the patient have any new symptoms of concern? and idiosyncratic reactions (clinical...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues",
      "referral",
      "psychoeducation"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn 68 EPI 3 EPILEPSY Follow-up 2 MONITOR TREATMENT At every contact: » » Evaluate side-effects of medication including adverse effects Does the patient have any new symptoms of concern? and idiosyncratic reactions (clinically and with appropriate laboratory tests Review for any new symptoms of depression and anxiety given when available). high risk of co-morbidity with epilepsy. » » Provide psychoeducation and review psychosocial interventions. Is the patient on any new medications that may have interactions? » (Many anticonvulsants have interactions with other medications). If so, Is the person a woman of childbearing age and considering consult a specialist. pregnancy? If so, consult specialist. 3 CONSIDER MEDICATION DISCONTINUATION WHEN APPROPRIATE Has the person been convulsion free for several years? » D iscuss risk of seizure occurrence with person/carer IF THERE ARE NO PROBLEMS WITH MEDICATIONS (if epilepsy is due to head injury, stroke or neuroinfection, » Continue at current dose. Correct dosing is lowest there is a higher risk of seizure recurrence off medication), therapeutic dose for seizure control, while minimizing and risks and benefits of discontinuing medications. adverse side-effects. » If in agreement, gradually take the person off » Continue close follow-up and review for possible dis- medication by reducing the doses over 2 months and continuation of medications once seizure free for at monitoring closely for seizure recurrence. least two years. CHILD & ADOLESCENT 68 epi 3 epilepsy follow-up 2 monitor treatment at every contact: » » evaluate side-effects of medication including adverse effects does the patient have any new symptoms of concern? and idiosyncratic reactions (clinical..."
}